Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cardinal Health Inc (CAH) vs Enveric Biosciences Inc (ENVB) Price & Performance

Cardinal Health IncTrade
Enveric Biosciences IncTrade

Price performance (Past 24H)

Key statistics

Cardinal Health Inc vs Enveric Biosciences Inc — how do they compare? Cardinal Health Inc trades at $240.57 (market cap $55.88B), while Enveric Biosciences Inc trades at $1.45 (market cap $6.20M). The key difference: Cardinal Health Inc is far larger — about 9012.9× Enveric Biosciences Inc's market cap, and Cardinal Health Inc pays a 0.86% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.

CAHENVB
Market Cap
$55.88B$6.20M
Sector
HealthHealth
52-Week High
$240.26$17.40
52-Week Low
$146.04$1.27
Enterprise Value
$59.91B$1.30M
Dividend Yield
0.86%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Cardinal Health Inc

Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.

Read more on CAH

About Enveric Biosciences Inc

Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.

Read more on ENVB